Dr. Fiona Noelle Denham, MD

Dr. Denham practices at Piedmont Athens Specialty Care in Athens, Georgia.

Dr. Denham's NPI, 1871892208, was assigned on March 24, 2011. Dr. Denham holds Indiana license 01078998A.

Dr. Denham's primary practice is Piedmont Athens Specialty Care, at 242 King Ave, Athens, GA 30606 in Clarke County. The practice phone is (706) 475-7000.

Dr. Denham's primary practice is Piedmont Athens Specialty Care in Athens, Georgia. Dr. Denham is also affiliated with Piedmont Athens Regional. The medical group on file is Piedmont Athens Regional. Dmand AI also links Dr. Denham to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Denham practices, 3 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Denham's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Denham is licensed in Indiana.

CMS data shows 169 Medicare services from Dr. Denham across 6 procedure codes in 2024, for 123 Medicare patients. Medicare paid $18,198 for them. Every service was in an office.

CMS counts 123 Medicare patients who saw Dr. Denham in 2024. The largest group is 65 to 74, with 65 patients. 75% of them have cancer, and 69% have high cholesterol. Their average risk score is 0.90, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Denham's median patient age at 58, with 99% women.

In 2024, Dr. Denham wrote 36 Medicare Part D claims for 15 patients. 97% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $24 in total drug cost. In 2022, CMS named 23 claims across 2 drugs.

Dr. Denham accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 13 procedures of mastectomy by Dr. Denham, more than 68% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Denham, published from 2014 to 2019. Dr. Denham's most frequent co-authors are Ronda Shirletta Henry-Tillman, MD, Meng-Fey Ferra Lin-Duffy, DO and Charles J. Link, MD.

Dmand AI links Dr. Denham to 2 clinical trials, 2 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Breast Neoplasms and Breast Diseases. Alliance for Clinical Trials in Oncology sponsors the most, 2.

CMS Open Payments shows 14 general payments to Dr. Denham from 10 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 95% of the total. Vector Surgical, LLC paid the most, $300.